Release Date: 18/02/09 10:33 Summary: SAI: SAI Global T/O - Update on Conditions Price Sensitive: Yes Download Document 31.45KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%